Comparable real‐world effectiveness between switches to cabotegravir + rilpivirine long‐acting or modern daily oral regimens in the United States: an OPERA cohort study
Journal of the International AIDS Society · 2025
DOI: 10.1002/jia2.70068 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of the International AIDS Society, 2025. Verfasst von Ricky K Hsu und 10 weiteren Autor:innen. Beteiligte Einrichtung: AIDS Healthcare Foundation, New York, New York, USA. Hauptthemen laut MEDLINE: Rilpivirine, HIV Infections, Anti-HIV Agents, Pyridones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction Cabotegravir + rilpivirine long‐acting (CAB+RPV LA) injectable was approved in the United States in 2021 for HIV‐1 treatment in virologically suppressed (viral load [VL]
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AIDS Healthcare Foundation, New York, New York, USA.
- NYU Langone Health, New York, New York, USA.
- CAN Community Health, Fort Lauderdale, Florida, USA.
- Epividian, Raleigh, North Carolina, USA.
- AIDS Healthcare Foundation, Fort Lauderdale, Florida, USA.
- ViiV Healthcare, Durham, North Carolina, USA.
Zitieren
APA
Hsu, R. K., Sension, M. G., Fusco, J. S., Brunet, L., Cochran, Q., Levis, B., Sridhar, G., Vannappagari, V., Wyk, J. V., Wohlfeiler, M. B., & Fusco, G. P. (2025). Comparable real‐world effectiveness between switches to cabotegravir + rilpivirine long‐acting or modern daily oral regimens in the United States: an OPERA cohort study. Journal of the International AIDS Society. https://doi.org/10.1002/jia2.70068
Vancouver
Hsu RK, Sension MG, Fusco JS, Brunet L, Cochran Q, Levis B, et al. Comparable real‐world effectiveness between switches to cabotegravir + rilpivirine long‐acting or modern daily oral regimens in the United States: an OPERA cohort study. Journal of the International AIDS Society. 2025. doi:10.1002/jia2.70068
BibTeX
@article{Hsu2025,
author = {Hsu, Ricky K and Sension, Michael G and Fusco, Jennifer S and Brunet, Laurence and Cochran, Quateka and Levis, Brooke and Sridhar, Gayathri and Vannappagari, Vani and Wyk, Jean Van and Wohlfeiler, Michael B and Fusco, Gregory P},
title = {Comparable real‐world effectiveness between switches to cabotegravir + rilpivirine long‐acting or modern daily oral regimens in the United States: an OPERA cohort study},
journal = {Journal of the International AIDS Society},
year = {2025},
doi = {10.1002/jia2.70068}
}
EUVIMED